Charles T. Coggin

Transoma Medical, Inc., headquartered in St. Paul, Minnesota, is a medical technology company engaged in developing, manufacturing and distributing implantable, wireless diagnostic and monitoring systems. Transoma is focused specifically on diagnostic and monitoring technology and dedicated to providing physicians with information needed to accurately and quickly diagnose unexplained, infrequent symptoms and to monitor changing, often asymptomatic complex arrhythmias. Transoma has an extensive technology platform based on more than 20 years experience in developing implantable wireless diagnostic systems for use in biomedical research. These innovative tools have played a key role in drug discovery, pre-clinical evaluation of safety and efficacy, and other academic and government basic research. Customers have turned to DSI for more accurate, timely physiological data, highly humane research practices, and faster times to market. In 2003 the Patient Management division was formed utilizing this proven technology platform and paving the way for the formation of Transoma Medical.

KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY.